Colin MD Broom's Net Worth

$14.1 Million

Estimate Recalculated Sep 8, 2024 07:18PM EST

Who is Colin MD Broom?

Colin MD Broom has an estimated net worth of $14.1 Million. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, Nabriva Therapeutics AG, VIROPHARMA INC, and NPS PHARMACEUTICALS INC.

SEC CIK

Colin MD Broom's CIK is 0001289946

Past Insider Trading and Trends

2011 was Colin MD Broom's most active year for acquiring shares with 15 total transactions. Colin MD Broom's most active month to acquire stocks was the month of December. 2014 was Colin MD Broom's most active year for disposing of shares, totalling 32 transactions. Colin MD Broom's most active month to dispose stocks was the month of December. 2012 saw Colin MD Broom paying a total of $702,090.04 for 183,393 shares, this is the most they've acquired in one year. In 2014 Colin MD Broom cashed out on 888,861 shares for a total of $8,705,872.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nabriva Therapeutics Plc No price found

Chief Executive Officer

Colin MD Broom owns 1,595 units of Ordinary Shares. In the year 2017 Colin MD Broom filed a total of 1 filing.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
157.41K
—
—
157.41K
Jun 23
No matching records found

Nabriva Therapeutics AG (NBRVF) Snapshot price: $0.000001

CEO & Director

Colin MD Broom owns 36,523 units of Ordinary Shares which is worth $0.04 and 97,151 units of Ordinary Shares F1 which is worth $0.10. In the year 2016 Colin MD Broom acquired a total of 130,265 shares in Nabriva Therapeutics AG at a cost of $106,878.27, Colin also disposed a total of 37,288 shares of Nabriva Therapeutics AG equalling to $50,950.51.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-12.75%
-5.34K
$0.19
-$1,015.48
36.52K
Aug 2
Form 4
-1.25%
-531.00
$1.20
-$637.20
41.86K
Aug 2
Form 4
+70.30%
17.5K
—
—
42.39K
Jul 28
Form 4
+10.03%
22.69K
$0.65
-$7,165.05
248.94K
Aug 19 - Aug 20
Form 4
+8.38%
17.5K
—
—
226.25K
Jul 29
Form 4
+5.13%
10.18K
$2.03
$20,668.47
208.75K
Aug 30
Form 4/A
-7.49%
-10.18K
$2.07
-$21,066.39
125.72K
Aug 21
Form 4
+23.08%
23.57K
$2.07
-$21,066.39
125.72K
Aug 19 - Aug 21
Form 4
—
0
—
—
0
Jul 31
Form 4
+5.15%
5K
$3.72
$18,600.00
102.15K
Jun 22
Form 4
+11.47%
10K
$4.60
$46,000.00
97.15K
May 23
Form 4
—
0
—
—
0
Jan 31
Form 4
+3.06%
2.59K
$8.35
$21,609.80
87.15K
Sep 22
Form 4
—
0
—
—
0
Feb 7
Form 3
—
0
—
—
0
No matching records found

VIROPHARMA INC No price found

VP & Chief Scientific Officer

Colin MD Broom owns 15,113 units of Common Stock for Sales. Colin MD Broom used to own units in Common stock but no longer holds any shares there.acquired a total of 513,519 shares in VIROPHARMA INC at a cost of $2,558,764.33, Colin also disposed a total of 543,044 shares of VIROPHARMA INC equalling to $15,587,539.07.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-154.06K
$50.00
—
0
Jan 24
Form 4
+380.59%
122K
$27.51
-$262,397.71
154.06K
Jan 8
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jan 3
Form 4/A
-46.46%
-17.50K
$22.53
-$394,301.25
20.17K
Scheduled
Dec 24
Form 4
+49.59%
10K
$1.84
$18,400.00
30.17K
Scheduled
Dec 27
Form 4
—
0
$12.19
-$362,101.25
37.67K
Scheduled
Dec 24
Form 4
—
0
$16.38
-$1,153,525.89
37.67K
Dec 10
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Jan 5
Form 4
+90.03%
17.5K
$1.84
$32,200.00
36.94K
Dec 23
Form 4
—
0
$17.02
-$831,250.00
19.44K
Scheduled
Dec 14
Form 4
—
0
$15.28
-$658,072.45
19.44K
Scheduled
Dec 12 - Dec 13
Form 4
—
0
$13.46
-$301,802.00
19.44K
Nov 7
Form 4
—
0
$11.68
-$762,101.32
19.44K
Oct 31 - Nov 1
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jan 5
Form 4
+16.73%
2.5K
$1.84
$4,600.00
17.44K
Dec 31
Form 4
—
0
$7.55
-$342,565.60
15.11K
Sep 9 - Sep 13
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jan 7
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jan 8
Form 4
-45.17%
-9.97K
$8.70
-$312,957.27
12.1K
Sep 12
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jan 11
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jan 12
Form 4
—
0
—
—
0
Aug 3
Form 4
—
0
—
—
0
Jan 17
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jan 21
Form 4
—
0
—
—
0
May 10
Form 3
—
0
—
—
0
No matching records found

NPS PHARMACEUTICALS INC No price found

Investor

Colin MD Broom used to own units in Common Stock but no longer holds any shares there.acquired a total of 45,638 shares in NPS PHARMACEUTICALS INC, Colin also disposed a total of 30,413 shares of NPS PHARMACEUTICALS INC equalling to $1,171,712.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-24.31K
$46.00
-$1,118,398.00
0
Feb 21
Form 4
—
0
—
—
0
Feb 12
Form 4
+166.44%
15.19K
—
—
24.31K
Feb 12 - Feb 13
Form 4
—
0
—
—
0
Feb 13
Form 4
∞
9.13K
$8.74
-$53,314.00
9.13K
Scheduled
Feb 7
Form 4
—
0
—
—
0
May 16
Form 4
∞
15.22K
—
—
15.22K
Feb 7
Form 4
—
0
—
—
0
Jan 17
Form 4
—
0
—
—
0
Oct 17
Form 4
—
0
—
—
0
Jul 15
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
Apr 15
Form 4
—
0
—
—
0
Jan 18
Form 4
—
0
—
—
0
Oct 15
Form 4
—
0
—
—
0
Jul 15
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
Apr 15
Form 4
—
0
—
—
0
Jan 15
Form 4
—
0
—
—
0
Oct 15
Form 4
—
0
—
—
0
Jul 9
Form 3
—
0
—
—
0
No matching records found